Coming Soon
Find information on Panic Disorder diagnosis, including DSM-5 criteria, ICD-10 code F41.0, clinical documentation tips, and medical billing guidelines. Learn about panic attack symptoms, differential diagnosis considerations, and treatment options for healthcare professionals. Explore resources for accurate coding and comprehensive documentation of Panic Disorder in clinical settings. This resource supports proper medical coding and billing practices for mental health professionals.
Also known as
Panic disorder
Recurrent unexpected panic attacks with persistent worry about future attacks.
Neurotic, stress-related disorders
Disorders characterized by anxiety, phobias, and other stress reactions.
Generalized anxiety disorder
Excessive worry and anxiety about various events or activities.
Other specified anxiety disorders
Anxiety disorders not classified elsewhere, such as mixed anxiety and depressive disorder.
Follow this step-by-step guide to choose the correct ICD-10 code.
Recurrent unexpected panic attacks?
When to use each related code
| Description |
|---|
| Unexpected panic attacks, fear of future attacks. |
| Fear of situations where escape is difficult. |
| Excessive worry about various things most days. |
Coding F41.9 (Panic Disorder, Unspecified) when a more specific code like F41.0 (Panic Disorder with Agoraphobia) is applicable, leading to under-reporting of severity.
Coding Panic Disorder as confirmed when documentation only supports a suspected or rule-out diagnosis, increasing the risk of inaccurate reporting and reimbursement.
Missing comorbid anxiety disorders (e.g., Generalized Anxiety Disorder F41.1) which commonly occur with Panic Disorder, impacting quality reporting and case mix index.
Q: How to differentiate between Panic Disorder and a Generalized Anxiety Disorder in clinical practice?
A: Differentiating between Panic Disorder (PD) and Generalized Anxiety Disorder (GAD) requires careful assessment of symptom presentation and temporal patterns. While both involve excessive anxiety, PD is characterized by recurrent unexpected panic attacks with persistent worry about future attacks and/or maladaptive behavioral changes related to the attacks (e.g., avoidance). Key differentiators include the paroxysmal nature of anxiety in PD, with discrete episodes of intense fear, versus the more persistent, chronic worry seen in GAD. GAD also features more prominent somatic symptoms like muscle tension, fatigue, and irritability. Explore how standardized assessment tools, such as the Panic Disorder Severity Scale (PDSS) and the Generalized Anxiety Disorder 7-item (GAD-7) scale, can aid in diagnostic clarity and track treatment response. Consider implementing a detailed symptom diary to help patients discern panic attacks from generalized anxiety symptoms. Learn more about the diagnostic criteria for both disorders as outlined in the DSM-5-TR and ICD-11.
Q: What are evidence-based first-line pharmacological treatment options for Panic Disorder in adult patients with comorbid depression?
A: For adult patients with Panic Disorder and comorbid Major Depressive Disorder (MDD), Selective Serotonin Reuptake Inhibitors (SSRIs) are generally considered first-line pharmacological treatment options. SSRIs like sertraline, paroxetine, and fluoxetine demonstrate efficacy in managing both conditions simultaneously. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), such as venlafaxine and duloxetine, are also considered effective. For patients with partial or non-responsive symptoms, augmentation with a benzodiazepine during the initial weeks of SSRI/SNRI treatment can be considered, though long-term benzodiazepine use should be avoided due to the risk of dependence. Explore the clinical guidelines from organizations like the American Psychiatric Association (APA) and the National Institute for Health and Care Excellence (NICE) for detailed recommendations on medication choice, dosing, and management strategies for comorbid PD and MDD. Learn more about the comparative efficacy and tolerability profiles of different SSRIs and SNRIs to inform personalized treatment decisions.
Patient presents with symptoms consistent with Panic Disorder (DSM-5 300.01, ICD-10 F41.0). The patient reports recurrent unexpected panic attacks, characterized by a sudden surge of intense fear or discomfort that reaches a peak within minutes. These panic attacks include at least four of the following symptoms: palpitations, pounding heart, or accelerated heart rate; sweating; trembling or shaking; sensations of shortness of breath or smothering; feelings of choking; chest pain or discomfort; nausea or abdominal distress; feeling dizzy, unsteady, light-headed, or faint; chills or heat sensations; paresthesias (numbness or tingling sensations); derealization (feelings of unreality) or depersonalization (being detached from oneself); fear of losing control or going crazy; and fear of dying. At least one of the attacks has been followed by one month or more of one or both of the following: persistent concern or worry about additional panic attacks or their consequences (e.g., losing control, having a heart attack, going crazy) and a significant maladaptive change in behavior related to the attacks (e.g., avoidance of exercise or unfamiliar situations). The panic attacks are not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication) or another medical condition (e.g., hyperthyroidism, cardiopulmonary disorders). The panic attacks are not better explained by another mental disorder (e.g., social anxiety disorder, specific phobia, obsessive-compulsive disorder, posttraumatic stress disorder, separation anxiety disorder). Differential diagnoses considered include generalized anxiety disorder, substance-induced anxiety disorder, and medical conditions such as cardiac arrhythmias. Treatment plan includes cognitive behavioral therapy (CBT) focused on panic management techniques, psychoeducation regarding panic disorder, and potential pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). Patient education provided on panic disorder symptoms, treatment options, and coping strategies. Follow-up scheduled to monitor symptom improvement and medication efficacy, if applicable. Referral to a psychiatrist may be considered for medication management or further evaluation.